Genome Web Breaking News
- ERS Genomics Licenses CRISPR Patents to German Startup Vivlion
- Stilla Technologies Partners With ID-Solutions for Oncology MDx
- Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings
- Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization
- BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark
Stat
- STAT+: STAT+ Conversations: A conversation on drug pricing, policy, and access
- White House to host Covid-19 vaccine summit, as Trump seeks to burnish record
- STAT+: Pharmalittle: Serum Institute threatens to sue Covid-19 vaccine trial participant; U.S. agency prepares for Covid-19 vaccine fraud
- STAT+: Agios drug for rare form of anemia achieves main goal of late-stage clinical trial
- Opinion: The U.S. must support access to care and incentives for the innovation that transforms it
NYT science news
Xconomy news
- Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
- Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
- Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
- Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies
- Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
Fierce Biotech
- Boston Scientific recoups $800M by selling off BTG’s antidote business
- Wilson, Penn ink Regeneron pact to use gene therapy tech to deliver COVID-19 antibodies
- Agios' anemia drug hits goal in phase 3, teeing up 2021 filing
- Noema bags $60M to take ex-Roche CNS drugs through phase 2b
- Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer
Fierce Medical Devices
- Boston Scientific recoups $800M by selling off BTG’s antidote business
- DeepMind AI breaks through decades-old protein folding puzzle
- MGH breast cancer researchers use AI to spot new details in mammograms
- AliveCor nets $65M, new FDA clearances for future telehealth plans
- NHS to pilot Grail's cancer-spotting blood test in 165,000 patients